PeptiFinder Biotech
PeptiFinder Biotech is the pioneering CRO specializing in mRNA display technology. At PeptiFinder, we leverage a superior mRNA display platform featuring a variety of libraries (linear, monocyclic and bicyclic peptides) with ultra-high-diversity (up to10^15) which can be screened against nearly any biological target of interest rapidly (6-8 weeks) with a remarkable success rate of over 95%. By incorporating unnatural amino acids into peptide libraries, PeptiFinder mRNA display platform can generate peptides with enhanced physiochemical properties and optimized pharmacokinetics. We also offer custom library designs tailored to specific client needs. In addition, PeptiFinder provides downstream services including ELISA/SPR hit confirmation, macrocyclic peptide DEL screening, peptide synthesis and hit optimization.
